A $120M clinical bet tops the stack

Six disclosed financings cleared the Aug. 28, 2026 08:45 AM PT cutoff. The largest confirmed check was AusperBio's $120M Series C, followed by Yardstik's $30M Series B; four European early-stage rounds filled the specialist middle.

AusperBio closed a $120M Series C led by an undisclosed strategic investor, with RA Capital Management joining as a new investor. Existing backers included HanKang Capital, Sherpa Capital, InnoPinnacle Fund, Qiming Venture Partners, YuanBio Venture Capital, and CDH Investments. The company said the round will advance AHB-137 toward a Phase 3 registrational program in China and commercialization readiness, while supporting AHB-171 and next-generation chronic-hepatitis-B combinations. AusperBio said total funding since 2024 reached $360M. 1

Yardstik raised a $30M Series B led by Harbert Growth Partners. Rally Ventures, MissionOG, Crosslink Capital, Grotech Ventures, and Great North Ventures participated; total funding reached $65M. Minneapolis-based Yardstik sells background screening, identity verification, fraud detection, and continuous post-hire monitoring for employers. The company said proceeds will support motor-vehicle reports, OIG exclusion monitoring, and alerts for expiring licenses, insurance, or certifications. 2

Lupin Dental closed a €15M Series A led by Fynveur, which invested €10M. Existing shareholders and private investors participated, with a Bpifrance loan alongside the round. The Montpellier company is developing a supervised robotic system for minimally invasive tooth preparation for aesthetic veneers. 3

Revier Therapeutics launched with a €6M seed financing led by KHAN Technology Transfer Fund II. High-Tech Gründerfonds, VORNvc, and private investors through Revier Invest Heidelberg participated. The Heidelberg biotech is developing orally available small molecules for cardiometabolic diseases, with heart failure with preserved ejection fraction and atherosclerotic cardiovascular disease as initial indications. 4

Clementine raised €1.7M in seed funding led by Healthy.Capital. The Maastricht startup's AI platform helps hearing clinics convert leads into patients; its hearing-care agent answers questions, educates prospective patients, and guides them toward bookings. 5

Nanolope closed an €800K pre-seed round backed by IBB Ventures through its pre-Seed Fund B# ('be sharp'), alongside business angels and industry experts. The Berlin DeepTech company develops building-surface materials that store thermal energy in walls, ceilings, and floors. 6

The week's read is narrow. The largest check is tied to a named clinical milestone, the second to a defined employer workflow, and the four European rounds to specific product or research bottlenecks. The six-deal sample supports attention to milestone-linked financing; the sample remains too small to rank the market or name a winning sector.